The FDA has accepted the resubmission of a BLA for odronextamab for the treatment of patients with relapsed/refractory ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

Diabetes develops silently, causing damage before diagnosis. Learn how early intervention can prevent complications and ...

Regulation is leading healthcare device manufacturers to think about cybersecurity from the outset to build and design ...

ModMed® (the "Company"), a pioneer in specialty-specific healthcare SaaS technology, today announced that Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") has made a ...

Everybody goes through their dinosaur phase. I got stuck on the volcano phase until I realized ... family prepare for the end and help the patient prepare for the end. My longest-term patient, who I ...

Natural products industry companies share overviews on the latest science on their branded ingredients and formulations to ...

Everybody goes through their dinosaur phase. I got stuck on the volcano phase ... the end and help the patient prepare for the end. My longest-term patient, who I had for three years, died two ...

One area and this is the area that we've been in the longest, is really in the area ... we’re now in the phase of just like you and I as consumers, we can order groceries or use a service ...

YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 ...

If Orca-T becomes the first allogeneic T-cell immunotherapy to gain FDA approval, Dimov believes it would help standardize the way patients are treated across different sites. The phase 3 results ...